In studies performed with PDLabs’ Transdermal Verapamil 15% Gel statistically significant improvements have been demonstrated in curvature reduction, pain, and plaque size. The graphs below summarize the results of a published 9 month, double-blind, placebo controlled study.
Transdermal Verapamil 15% Gel Clinical Data: Peyronie’s Disease
57 Patient Double-blind placebo-controlled study – This 4 armed study compared PDLabs’ Transdermal Verapamil 15% Gel to two other drugs and placebo to determine efficacy and safety of the medication.
645 Patient Study – This open-label study evaluated the efficacy and safety of PDLabs’ Transdermal Verapamil 8% Gel
214 Patient Study – This open-label study evaluated the efficacy and safety of PDLabs’ Transdermal Verapamil 8% Gel
Skin Penetration Study – A study demonstrating the ability of PDLabs’ Transdermal Verapamil 15% Gel to successfully penetrate to the tunica albuginea.
